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Regulation of arterial lesions in mice depends on
differential smooth muscle cell migration: A role
for sphingosine-1-phosphate receptors
Shinya Inoue, MD,a Tatsu Nakazawa, MD,a Aesim Cho, PhD,a Frank Davastan, BS,a Dustin Shilling,
BS,b Günter Daum, PhD,b and Michael Reidy, PhD,a Seattle, Wash
The response of mice arteries to injury varies significantly between strains. FVB mice develop large neointimas after
injury, whereas very small lesions form in C57BL/6 mice. After injury, platelet interaction with the denuded artery and
early smooth muscle (SMC) replication are identical in both strains; however, the migration of SMCs differs significantly.
FVB cells readily move into the developing neointima, whereas only the occasional C57BL/6 cells migrate. Injured
arteries showed no difference in matrix metalloproteinases (MMP-2 and MMP-9) and plasminogen activator activities.
In vitro, sphingosine-1-phosphate (S1P) in combination with platelet-derived growth factor (PDGF) stimulates
migration of FVB cells but inhibits migration of C57BL/6 SMCs. Both SMCs migrate equally well to PDGF alone. One
explanation is that the SMCs express different S1P receptors. Real-time polymerase chain reaction shows that FVB cells
express higher levels of S1P receptor-1 (S1P1) compared with C57BL/6 cells, which express higher levels of S1P
receptor-2 (S1P2). In addition, the migration of C57BL/6 cells can be increased by inhibiting S1P2, whereas inhibiting
S1P1 expression slows the migration of FVB cells. Taken together these studies suggest that expression of S1P receptors
vary within inbred mouse strains and that S1P is critical for SMC migration and lesion formation after injury. (J Vasc
Surg 2007;46:756-63.)
Clinical Relevance: This report shows that the arteries of C57BL/6 and FVB mice vary in their ability to develop arterial
neointimal lesions after injury. A major difference relates to ability of FVB smooth muscle cells to migrate into the intima
and so develop neointimal lesions. In vitro FVB cells migrate well in response to sphingosine 1-phosphate (a component
of plasma) but C57BL/6 cells do not. FVB cells express sphingosine-1-phosphate (S1P1) and low levels of S1P2
receptors, whereas C57BL/6 cells show higher S1P expression. These data suggest that differences in S1P receptor2
expression are important role in the formation of neointimal lesions.Intimal thickening accompanied with lumen reduction
plays a critical role both in arterial restenosis and atherosclero-
sis. Smoothmuscle cells (SMCs) are a key component of these
lesions, and as such, a multitude of studies have been done to
understand how the proliferation of these cells is regulated.
Much of our understanding on the growth of SMCs in vivo
comes from studies in which arteries are deliberately injured
and subsequently develop a thickened intima.
Harmon et al1 first noted that the size of injury-induced
intimal lesions in mice arteries was strain-dependent. The
technique used in these studies to stimulate neointimal
lesions was rather unusual and involved the complete liga-
tion of the carotid artery. Why a neointima should form
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756under these conditions is not understood, but other exper-
iments, including our own in which a more traditional
arterial injury was used, gave almost identical results.2,3
It appears therefore that genetic variations significantly
regulate neointimal formation in mice.
The aim of this study was to examine the arteries of two
mice strains with very different responses to injury and
resolve which cellular events, known to be critical for lesion
growth, were impaired or different. The major finding of
this study is that SMCs of C57BL/6 and FVB mice show a
significant difference in their ability to migrate and we
believe this is responsible for the difference in lesion size.
We further show that differential expression of sphingosine
1-phosphate (S1P) receptors renders S1P promigratory in
FVB SMCs and antimigratory in C57BL/6 SMCs. This
difference might contribute to the strain-dependence of
neointimal formation in injured mice arteries.
MATERIALS AND METHODS
Surgical procedure. Arteries in male mice (7 to 8
weeks old) were injured with a 6-0 monofilament catheter
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passed to the level of the carotid aortic bifurcation as
previously described.4 The catheter was then continuously
rotated and slowly pulled back to the carotid bifurcation.
This was repeated three more times. All studies were done
within the guidelines for animal experimentation at the
University of Washington.
In vivo proliferation assay and morphometry. Mice
were injected intraperitoneally with bromodeoxyuridine
(BrdU, 30 g/g body weight) at 1, 9, and 17 hours before
euthanasia. Carotid arteries were perfusion-fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 3
minutes in situ. The arteries were then cut in two pieces at
mid-length. Sections were prepared from the two segments
starting at the cut end and then every 50 m to obtain
sections from six different sites (50 m apart). Sections
were then stained with hematoxylin and immunohisto-
chemically stained with BrdU (Boehringer-Mannheim, In-
gelheim, Germany) as previously described.4
Morphometric analysis of cross-sectional areas was per-
formed on arterial sections by using computer-assisted image
analysis (National Institutes of Health Image, Bethesda,Md).
Hematoxylin-positive (total) and BrdU-positive (replicating)
cells were counted on arterial sections.
Scanning electron microscopy. Mice arteries were
perfused fixed with 4% paraformaldehyde and dehydrated
tissue was examined by scanning electron microscopy
(SEM). Ten images were taken of the artery at the same
magnification, and platelet number was quantitated with a
point-hit technique.
Zymography. Carotid arteries were processed as pre-
viously described.4 Total protein (10 g) was loaded onto
8% polyacrylamide gels containing 0.1% type I gelatin
(Sigma, St Louis, Mo) for matrix metalloproteinase
(MMP) activity and 0.1 % casein plus 14 g/mL of plas-
minogen (Sigma) for plasminogen activity. After electro-
phoresis, the gels were incubated for 16 to 18 hours at
37°C and stained with Coomassie blue.
Mouse arterial smooth muscle cell isolation. Arterial
SMCs were isolated from mouse carotid arteries by an
enzyme dispersion approach using an enzyme mix of
2 mg/mL bovine serum albumin, 1 mg/mL collagenase,
0.375 mg/mL soybean trypsin inhibitor, and 0.125
mg/mL elastase type III in Hanks’ balanced salt solution.
After 10 minutes’ incubation, the adventitial layer was
removed, and the remaining tissue was incubated at 37°C
for a further 2 hours. Cells were collected by centrifugation
and placed in media containing 20% fetal bovine serum.
In vivo and in vitro migration assays. For in vivo
migration, carotid arteries were perfusion-fixed at 7 days
after injury as described previously and the vessels were
opened longitudinally and pinned down onto agar plate
with the luminal surface facing upward. Arteries were
stained with hematoxylin. Migrated SMCs were identified
as the hematoxylin-stained cells on the luminal surface of
the endothelium-denuded area. The total number of mi-
grated SMCs was counted.For in vitro migration, 1 105 cells were placed in the
upper chamber of a 24-well Transwell (Costar, Corning
Inc, Corning, NY) precoated with 0.1% type I collagen, and
the medium containing 20 ng/mL platelet-derived growth
factor (PDGF) or 1mol/L S1P, or both, was added to the
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Fig 1. A, Neointimal lesions in FVB and C57BL/6 carotid arter-
ies after injury. A small neointima can be seen (c) by 14 days, which
(d-e) became significantly larger at 28 and 42 days in FVB arteries.
Few neointimal cells can be seen (f-j) in C57BL/6 arteries at any
time (n  5 for each time point). The bar represents 0.1 mm.
B, Quantification of intimal SMCs in injured FVB (clear bars) and
C57BL/6 arteries (filled bars). At 14, 28, and 42 days, a significant
increase in neointimal cell number was detected in FVB arteries. All
values are standard deviations. *Significant at P  0.05.lower chamber. After 7 hours, cells on the lower surface
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The cells on the lower surface of membranes (9 fields/
membrane) were then counted under a microscope at40
magnification. The data are expressed as the mean number
of cells/field.
Quantitative polymerase chain reaction. Compli-
mentary DNA was prepared from each sample by treating
RNA with DNase I (Promega, Madison, Wis) and reverse
transcribed using Superscript reverse transcriptase (Promega).
The expression of S1P1 and S1P2 was quantitated using a
Taqman Sequence Detection Assay (PE Biosystems, Foster
City, Calif). The fluorogenic probe, CGCCGCCTGACCTTC-
CGCwasused forS1P1andTCCGCTCCAGCCACGCGGfor
S1P2. Forward and reverse primers for S1P1 were CTACTC-
CTTGGTCAGGACTCGAA and ACTCAGGACAATGAT-
CACCGTCTT. For S1P2 the forward primer was GTG-
GCTCTGTACGTCCGAATCTA, and the reverse primer
CTAGCGTCTGAGGACCAGCAA. The same RNA sam-
ples were polymerase chain reaction (PCR) amplified for 18S
and the S1P receptor expression was normalized to the 18S
Fig 2. Smooth muscle cell (SMC) replication in FVB and
C57BL/6 cells after injury. A, Medial SMC replication increased
in both FVB (clear bars) and C57BL/6 arteries (filled bars) at 2
and 4 days after injury, but a significant difference in SMC replica-
tion between these arteries was observed only at 7 days. B, Intimal
SMC replication was high after 7 days and to a lesser extent at 14
days. No increase was observed at 28 and 42 days. No replicating
neointimal SMCs were detected in C57BL/6 arteries. All values
are standard deviations. *Significant at P 0.05. BrdU, Bromode-
oxyuridine.expression.Primers for PAI-1 were 5=AGATGACCACAGCGGG-
GAAAAC and 3=AGAGGGCATTCACCAGCACCAG and
for TIMP-1 were 5=GCATCTCTGGCATCTGGCATCC
and 3=GCACACCCCACAGCCAGCACTA.
Small interfering RNA transfection. SMCs were
transfected with S1P1 and S1P2-small interfering (si)
RNA oligomers at 2 mol/L concentrations (Invitro-
gen, Carlsbad, Calif) using an electroporation system
(Amaxa Biosystems, Cologne, Germany). Cells were
then allowed to recover for 24 hours in presence of 10%
serum and siRNAs. Cells were serum-starved for addi-
tional 48 hours and then subjected to an in vitro migra-
tion assay as described above.
Statistical analysis. Differences between groups were
evaluated by the unpaired Student t test. All data were
considered significant at P  .05.
RESULTS
Response of FVB and C57BL/6 carotid arteries to
denuding injury. Intimal SMCs were observed in FVB
arteries at day 7 and their number and the size of the neointi-
mal lesions increased with time up to 42 days (Fig 1). No
significant lesions developed in C57BL/6 arteries. The size
of the media measured by determining the area enclosed by
internal and external elastic lamina showed no change after
Fig 3. Quantitation of smooth muscle cell migration onto the
luminal surface of injured FVB (clear bars) and C57BL/6 carotid
arteries (filled bars). The number of lumenal cells was assessed
along the entire length of the artery and expressed as cells/total
area measured. All values are standard deviations. *P  0.05 (11
mice/group).injury in either mice strain (data not shown).
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was elevated in both FVB and C57BL/6 arteries compared
with uninjured arteries; however, by day 7, replication was
significantly higher in FVB arteries (Fig 2, A). Intimal cell
replication was first detected in FVB arteries by day 7 and
remained elevated at day 14; thereafter, cell replication
decreased to almost undetectable levels (Fig 2, B). Owing
to the infrequency of intimal SMCs in C57BL/6 arteries,
no data are presented.
Migration of smooth muscle cells in injured FVB
and C57BL/6 arteries. Migration of SMCs was evalu-
ated by counting en face the number of SMCs on the entire
luminal surface of the artery 7 days after injury. This time
was chosen since SMCs are first observed on the luminal
surface at this time.4 As shown in Fig 3, there was
significantly less migration in C57BL/6 arteries com-
pared with the FVB mice at day 7.
We have previously reported that inhibition of SMC
migration to the intima profoundly limits the size of the
developing neointimal lesion and so we next investigated
those events known to regulate SMC migration in an
injured artery. The absence of platelets adhering to
exposed subendothelium, such as in a thrombocytopenic
Fig 4. A, Scanning electron micrographs showing platelet adher-
ence on the denuded surface of injured FVB and C57BL/6 carotid
arteries 1 hour after denudation. Bar 10 m. B, The percentage
of the denuded surface covered with platelets was quantitated from
15 micrographs for each artery (n  5). All values are standard
deviations.animal, can significantly block SMC migration5 ; how-ever, a normal platelet response was noted in both strains
(Fig 4).
Several studies, including our own, have shown that
MMPs and plasmin play an important role in SMC migra-
tion in injured arteries.4 We therefore examined the activ-
ities of MMP-9, MMP-2, urokinase plasminogen activator
(uPA), and tissue plasminogen activator (tPA) at the time
when cells are known to be migrating from the media onto
the luminal surface. No difference was observed in MMP-9
and MMP-2 or in uPA and in tPA activities as assessed by
zymography between FVB and C57BL/6 injured arteries at
the time when migration is known to occur (Fig 5, A and B).
The expression of TIMP-1 andPAI-1was similar for both sets
of arteries 7 days after injury (data not shown).
Sphingosine 1-phosphate and smooth muscle cell
migration. Recently S1P, a sphingolipid metabolite,
has been found to influence SMC migration. S1P caused
a dose-dependent increase in migration of FVB but
decreased migration of C57BL/6 cells (Fig 6, A) . Also, S1P
in combination with PDGF increased FVB migration but
Fig 5. Activity of matrix metalloproteinases (MMPs) and plas-
minogen activators in injured FVB andC57BL/6 carotid arteries 7
days after injury. A, Zymogram containing gelatin shows MMP-9
and MMP-2 activities. B, Zymogram containing plasminogen and
casein shows urokinase plasminogen activator (uPA) and tissue
plasminogen activator (tPA) activities. The study was repeated
three times and showed similar results.exerted the opposite effect and inhibited PDGF-induced mi-
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PDGF alone was similar for both cells, suggesting no
difference in PDGF receptor expression (Fig 6, B).
Sphingosine 1-phosphate receptor expression. SMCs
express several S1P receptors and their activation can initi-
ate different outcomes.6,7 We therefore asked if differences
in migratory ability of FVB and C57BL/6 cells is linked to
expression of specific S1P receptors. Using real-time PCR
we found that S1P1 expression was stronger in FVB com-
pared with C57BL/6 SMCs. In contrast, the S1P2 receptor
was expressed at higher level in C57BL/6 cells (Fig 7).
We then determined if down-regulation of S1P recep-
tors by siRNA influences SMC migration. Inhibition of
S1P1 expression in FVB cells reduced their ability to mi-
grate in response to S1P (Fig 8, A and B). Migration in
response to PDGF was not changed. Treatment of
C57BL/6 cells with the same siRNA also reduced S1P1
expression but had no effect on migration in response to
S1P, PDGF, and a combination of both factors (Fig 8, A
Fig 6. In vitro migration of FVB and C57BL/6 smooth muscle
cells (SMCs). A, Migration of SMCs in response to 0, 0.1, 1, 10
and 20 mol/L of sphingosine-1-phosphate (S1P). Dotted line,
FVB; solid line, C57BL/6. B, Cells were stimulated with 1
mol/L S1P, 20 ng/mL platelet-derived growth factor-BB
(PDGF), and S1P and PDGF together (B). Each experiment was
performed in triplicate and repeated three times. *P  0.05. All
values are standard deviations.and C). Inhibition of S1P2 expression in FVB andC57BL/6 cells (Fig 9, A) promoted the migration of these
cells in response to S1P and to a combination of PDGF and
S1P (Fig 9, B and C). We therefore conclude that S1P2 is
the dominant receptor in C57BL/6 cells and retards SMC
migration, whereas S1P1, the dominant receptor in FVB,
SMCs stimulates migration.
DISCUSSION
Response of FVB and C57BL/6 arteries to injury.
In this study, we chose to examine C57BL/6 and FVB
mice because there are data showing differences in the
response of arteries to injury. Indeed, several laboratories,
including ours, show that C57BL/6 arteries develop only
small or no neointimal lesions after injury whereas FVB
arteries form large neointimal lesions.1-3,8 This finding is
somewhat controversial because other laboratories show
significant neointimal lesions in C57BL/6 arteries.9-12
It is difficult to resolve this disparity, although one
explanation may be found in the way that arteries are
injured. Unfortunately, there is no standard technique to
denude or injure mice arteries and most laboratories man-
ufacture their own catheters. These vary from metal guide-
wires and catheters with a variety of modifications to exter-
Fig 7. A, Real-time polymerase chain reaction (RT-PCR) shows
expression of sphingosine-1-phosphate (S1P) receptors 1 (S1P1)
and 2 (S1P2) in FVB and C57BL/6 smooth muscle cells. The data
are expressed as the relative quantification of S1P receptors expres-
sion in C57BL/6 relative to the amount in FVB cells, which is set
to one, and are presented with the standard error. Each experiment
was repeated three times. *P  .05. B, RT-PCR products of same
samples (25 cycles). GAPDH, Glyceraldehyde-3-phosphate dehy-
drogenase.nal cuffing of the artery as well as complete or partial
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the degree of trauma inflicted on the artery will likely vary,
and authors have commented that lesions form at sites
where the internal elastic lamella is ruptured, a phenome-
non that we also observed.16
In our study, arterial injury was inflicted by passing a
loop of 6-0 monofilament into the carotid artery. This
method is similar to one we described for use in the rat.15
An advantage of this procedure is that over-distension of
the arterial wall is limited due to size and pliability of the
filament and rupture of the elastic lamella does not occur.
Steel guidewires and rigid catheters have a greater likeli-
hood of inflicting severe trauma to the artery. Several
techniques commonly used to elicit neointimal lesions in
mice arteries, such as external cuffing or blood flow restric-
tion, do not denude the artery, and so the events that
propagate neointimal lesions are likely to be different from
experiments that induce endothelial denudation and plate-
let interaction with the luminal surface.
This disparity in the response of mice arteries makes the
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Fig 8. Migration of smooth muscle cells transfected with small
interfering RNA (siRNA) targeting sphingosine-1-phosphate
(S1P) receptor 1 (S1P1). A, Real-time polymerase chain reaction
shows S1P1 receptor expression is down-regulated in both FVB
and C57BL/6 cells with siRNA targeted to S1P1 (2 mol/L)
and control siRNA (2 mol/L). Insert shows RT-PCR prod-
ucts. Both (B) FVB and (C) C57BL/6 were then stimulated
with 1 mol/L S1P, 20 ng/mL platelet-derived growth factor
(PDGF), and a combination of both factors for both cells. Migra-
tion was determined after 7 hours (n  3). All values are standard
deviations. *P  0.05.interpretation of studies difficult. The results are consistentwithin each laboratory, yet important differences must have
occurred although not currently recognized. With our
procedure, we find consistently that C57BL/6 arteries
develop small or no lesions, whereas FVB arteries invariably
show significant neointimal lesions. This has held true for
200 mice of each strain.
FVB smooth muscle cells migrate well, but C57BL/6
cells do not. To understand why there are such marked
differences between the arteries of these mice strains, we
examined those cellular events thought to be necessary in
the formation of neointimal lesions. The selection of the
events to be studied was based on our extensive data
derived from injured rat arteries and includes loss of endo-
thelium, adherence of platelets, and SMC migration and
replication.17,18
The first events known to have a major impact on the
development of arterial lesions are loss of endothelium and
the adherence of platelets. Platelets are known to regulate
SMC migration, and this was thought to be due to the
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Fig 9. Migration of smooth muscle cells transfected with small
interfering RNA (siRNA) targeting 2 mol/L sphingosine-1-
phosphate (S1P) receptor 2 (S1P2) and 2 mol/L control siRNA.
A, Real-time polymerase chain reaction (RT-PCR) results show
that S1P2 expression is downregulated in both cells. Insert shows
RT-PCR product of same samples. The (B) FVB (B) and (C)
C57BL/6 cells were then stimulated with 1 mol/L S1P, 20
ng/mL platelet-derived growth factor (PDGF) and a combination
of both factors for both cells. Migration was determined after 7
hours; n  3. All values are standard deviations. *P  0.05.release of PDGF.5,19,20 In both sets of arteries, the injury
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lets adhering to the injured surface was identical. Injury also
triggers medial SMC replication, possibly by releasing
fibroblast growth factor 2 from the traumatized SMCs.19
Of interest is that both C57BL/6 and FVB arteries show a
similar increase in medial replication at 2 and 4 days after
injury. This last fact is significant because it suggests that
there are no differences in the availability of growth factors
or growth inhibitors for SMCs early after injury. The dif-
ference between these two strains presumably lies with
events beyond this time period.
The first significant difference between the injured
arteries of the two strains was noted at day 7, where
migration of SMCs into the neointima was found to be
significantly greater in FVB than in C57BL/6 arteries.
Migration of SMCs is a critical event for the formation of a
neointima in mice because these arteries do not normally
possess an intima with SMCs and, consequently, cells must
migrate from the media to the intima for neointimal
growth to occur. Indeed, several studies have recently
shown that if migration is blocked, then the formation of
intimal lesions is completely retarded.5,21-23 Proteolytic
enzymes involved in this process include the plasminogen
activators, tPA and uPA, as well as MMP-9 and MMP-2.
One possibility, therefore, is that the mice strains used in
this study vary in the expression of MMPs or proteases and
this might explain why migration and the ultimate size of
the lesions are so different. Our data show that this hypoth-
esis is unlikely to be true because the activity ofMMP-9 and
MMP-2 and of the plasminogen activators uPA and tPA are
similar at those times when migration is known to occur
and no changes were found in TIMP-1 or PAI-1 expres-
sion.
In recent years, the sphingolipid S1P has been identi-
fied as a key regulator of cell motility.24-29 S1P stimulates
migration of several cells, yet interestingly, it inhibits SMC
migration.6,7,30-32 One reason why S1P might be impor-
tant for the development of neointimal lesions is that S1P is
released from platelets and so will be present at sites of
arterial injury.33,34 Further, a recent report showed that
S1P levels in humans are predictive of future vascular
events.35 Because S1P can regulate SMC motility, we
therefore asked if cells of these two mice strains respond
differently to S1P. Our data show that S1P stimulated
migration of FVB SMCs and, in combination with PDGF,
the effect was additive. In contrast, S1P did not stimulate
C57BL/6 cells and reduced the ability of cells to migrate
towards PDGF. Thus, S1P modulates the migration of
SMCs from C57BL/6 and FVB arteries, but in an opposite
manner.
We next asked how S1P might regulate such different
responses in SMCs from C57BL/6 and FVB strains. Be-
cause there are reports that differences in S1P receptor
expression can influence SMCmotility in opposite ways, we
examined S1P receptor expression in C57BL/6 and FVB
SMCs.7,32,33 There are five known S1P receptors, S1P1-5
although only S1P1, S1P2, and S1P3 are expressed by
SMCs.35 The deletion of S1P1 is lethal, and these mice diein utero because of incomplete vascular maturation.36 In
particular, there is a defect in the recruitment of SMCs and
pericytes to the developing blood vessels. The expression of
S1P2, however, is linked to inhibition of migration, and this
receptor is thought to be the dominant S1P receptor ex-
pressed by many SMCs.32 C57BL/6 cells would fit into
this category because they strongly express S1P2, and more
important, S1P blocks their migration. FVB SMCs, how-
ever, strongly express S1P1 and less S1P2, and their migra-
tion is increased by S1P. FVB SMCs, therefore, differ from
the reported response of most SMCs.
To validate our hypothesis that differences in S1P re-
ceptor expression can account for the differences in SMC
migration, we altered their expression. S1P1 and S1P2
expression was inhibited in C57BL/6 and FVB using
siRNA targeted to each S1P receptor. A reduction of S1P2
in C57BL/6 cells now promoted cell migration in response
to S1P alone and combined with PDGF. A similar treat-
ment also increased the migration of FVB cells. Targeting
S1P1 inhibited FVB SMC migration but had no effect on
C57BL/6 SMCs. These data suggest that it is not the
absolute level of S1P receptor but rather the balance of
expression of the two receptors that decide if SMC migra-
tion is inhibited or promoted.
CONCLUSION
We have confirmed that injury to carotid arteries of FVB
and C57BL/6 triggers different arterial responses reflecting a
large difference in neointimal growth. The critical difference
between these strains is related to the ability of SMCs to
migrate to the intima. This migratory phenotype is main-
tained in vitro when cells are stimulated with S1P. We further
demonstrate that different expression of S1P1 and S1P2 re-
spectively regulate this phenotype. This work provides a basis
to explain the difference between the arteries of these two
strains and suggests an important role of S1P receptors expres-
sion in the development of arterial lesions.
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